Aptamer Group
Ian is an experienced CEO and Chairman of life sciences companies. He is currently Chairman of Genedrive plc (listed on AIM) and Cytox Limited. From 2014-2021 he was Chairman of Horizon Discovery Group plc before its recent sale to Perkin Elmer, Inc. From 2008 to 2011 he was CEO of Axis-Shield plc, a main market listed global diagnostics company that was sold to Alere Inc. for £260 million in 2011. Ian previously worked at GlaxoSmithKline as Vice President – Pharmacogenetics and previously held international general management, marketing, business development and R&D positions with Abbott Laboratories. Ian served as Chairman of Multiplicom N.V. between 2013 and it’s sale to Agilent in 2017. He holds a life sciences Ph.D. from the University of Bath and a degree in zoology from the University of Wales.
Ian Chairs the Remuneration Committee.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Aptamer Group
Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.